SOUTH AFRICA
Regulatory and Ethical Procedures
Before a clinical trial can be conducted, the sponsor has to submit an application to the South African Medicines Control Council (MCC), and obtain approval. This review process can take up to 4 or 5 months.

Moreover, approval is also required from an approved Ethics Committee. The Ethics Committee opinion will be provided within about 2 months.

The Guidelines for Good Clinical Practice and the Declaration of Helsinki must be observed. All investigators must have clinical trial experience (i.e. they must at least have been a co-investigator before) and must have attended a GCP course.

Clinical trials performed in Africa are registered in the African Trials Register.
Health Care System
The Department of Health is committed to improving the quality of health care, improving access to health care for all South Africans, improving efficiency and reducing inequity. To this purpose it was decided in the 1990s to restructure the health system, creating a decentralised national health system and introducing a district health system.

The clinical trial industry has grown considerably over the past years. South Africa possesses high technological medical expertise and infrastructure, and there is a racial and cultural diversity among the population.
Special feature
85% of the human genomic diversity is represented in South Africa.
Authorities
Department of Health
Medicines Control Council (MCC)
Medical Research Council (MRC)